ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W905. A total of 4 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $91,020 | -23.3% | 41,000 | -7.4% | 0.00% | – |
Q1 2024 | $118,724 | -71.2% | 44,300 | -67.9% | 0.00% | – |
Q4 2023 | $412,022 | +2349.7% | 137,800 | +1038.8% | 0.00% | – |
Q2 2023 | $16,819 | -88.9% | 12,100 | -87.3% | 0.00% | – |
Q1 2023 | $151,527 | -84.6% | 95,300 | -39.5% | 0.00% | – |
Q4 2022 | $981,225 | -9.8% | 157,500 | -3.0% | 0.00% | – |
Q3 2022 | $1,088,000 | +50.7% | 162,400 | +43.0% | 0.00% | – |
Q2 2022 | $722,000 | – | 113,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Warberg Asset Management LLC | 10,000 | $22,200 | 0.00% |
GROUP ONE TRADING, L.P. | 277,600 | $616,272 | 0.00% |
SIMPLEX TRADING, LLC | 289,500 | $642 | 0.00% |
JANE STREET GROUP, LLC | 41,000 | $91,020 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |